One menopause service quotes a visit. Another leads with a monthly membership. A pharmacy then prices the prescription separately. These numbers may all be accurate and still leave you without a clear picture of what care will cost.
Before comparing the smallest number on each page, ask what you would pay at the beginning, during ongoing care, and if the plan changes. The examples here come from public pages checked September 23, 2026, and require confirmation for your circumstances.
Request an itemized estimate for the first visit, the prescription, and ongoing follow-up.
Visits and membership are different purchases
Midi’s public pricing lists a $250 self-pay initial visit and a $150 self-pay return visit. Insurance costs depend on the plan and benefit details. Evernow describes pay-per-visit care and a separate membership model, so its membership headline should not be compared directly with a complete visit-plus-medication estimate.
Our Midi review and Evernow review explain those structures. Neither public price establishes what your insurer will pay or what your clinician will prescribe.
Reading behind this section: Midi Health: pricing and insurance · Evernow: current FAQs
Check the billing term
Evernow’s FAQ lists $49 monthly, $129 for three months, or $420 for twelve months, equivalent to $35 per month for the annual option. A separate enrollment offer reviewed during research displayed different annual pricing. That mismatch is a reason to check the terms shown in your actual enrollment flow.
A monthly equivalent may require a larger upfront payment. Ask about renewal dates, cancellation, refunds, what happens to messaging access, and how care continues when membership ends.
Reading behind this section: Evernow: current FAQs · Evernow: alternate enrollment offer
Put the prescription on its own line
The chosen drug, pharmacy, quantity, insurance formulary, and refill schedule can affect medication spending. A membership may not include medication, visits, or laboratory charges. Do not assume that “access to treatment” means the medicine itself is covered.
Ask whether the proposed option is an FDA-approved product or a compounded preparation and why. Our formulation comparison explains why price is not the only difference between those categories.
Reading behind this section: Midi Health: pricing and insurance · Evernow: current FAQs · FDA: compounding questions and answers
Leave room for follow-up
A realistic estimate includes the next appointment and any clinically appropriate monitoring, not just the first shipment. Ask what happens if symptoms persist, a medicine needs changing, or the service cannot continue treating you in your state.
The online-care shortlist is a starting point for asking these questions, not a promise of eligibility or a ranking of clinical outcomes. Our featured partner has an explicitly unconfirmed menopause service, so we do not publish a verified HRT price for that brand.
Reading behind this section: ACOG: hormone therapy for menopause · HHS: telehealth licensing · CoreAge Rx: public treatment catalog
Our source notes
- Midi Health: pricing and insurance
Provider prices and coverage descriptions; not a verified claim for any individual insurance policy.
- Evernow: current FAQs
Public care models and prices checked September 23, 2026; medication and visit costs may be separate.
- Evernow: alternate enrollment offer
This landing page displays a different annual membership offer from the main FAQ. Confirm the terms of the actual enrollment path.
- FDA: compounding questions and answers
Compounded medication is not FDA-approved.
- ACOG: hormone therapy for menopause
Clinical patient guidance; individual history and the actual product label still govern treatment decisions.
- HHS: telehealth licensing
Patient location and clinician authorization matter; this is not a state-specific legal opinion.
- CoreAge Rx: public treatment catalog
Commercial catalog checked September 23, 2026. A current menopausal HRT service was not confirmed.
